Lin‐Lin Bu

7.5k total citations · 3 hit papers
128 papers, 5.8k citations indexed

About

Lin‐Lin Bu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Lin‐Lin Bu has authored 128 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 43 papers in Molecular Biology and 36 papers in Immunology. Recurrent topics in Lin‐Lin Bu's work include Nanoplatforms for cancer theranostics (25 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Immune cells in cancer (15 papers). Lin‐Lin Bu is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Immune cells in cancer (15 papers). Lin‐Lin Bu collaborates with scholars based in China, United States and Australia. Lin‐Lin Bu's co-authors include Zhi‐Jun Sun, Wen‐Feng Zhang, Lang Rao, Wei Liu, Guang‐Tao Yu, Shishang Guo, Bo Cai, Xingzhong Zhao, Liang Mao and Andrew Li and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Lin‐Lin Bu

114 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer Cell Membrane‐Coated Upconversion Nanoprobes for Highly Specific Tumor Imaging

2016 475 citations Lang Rao, Lin‐Lin Bu et al. profile →
Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy

2017 470 citations Lang Rao, Bo Cai et al. ACS Nano profile →
Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance

2015 431 citations Lang Rao, Lin‐Lin Bu et al. Small profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin‐Lin Bu China	37	2.5k	2.4k	1.6k	1.6k	1.5k	128	5.8k
Michael S. Goldberg United States	30	1.5k 0.6×	2.5k 1.0×	1.6k 1.0×	1.9k 1.2×	1.1k 0.7×	40	5.7k
Bing Feng China	43	3.1k 1.2×	2.3k 1.0×	1.3k 0.8×	1.6k 1.0×	1.4k 0.9×	102	6.1k
Simon T. Barry United Kingdom	38	1.5k 0.6×	2.8k 1.1×	1.4k 0.8×	808 0.5×	1.4k 0.9×	123	6.1k
Song Shen China	39	2.4k 1.0×	2.2k 0.9×	945 0.6×	1.2k 0.7×	1.6k 1.0×	82	5.0k
Guang‐Tao Yu China	32	1.6k 0.6×	1.6k 0.7×	1.3k 0.8×	1.4k 0.9×	831 0.5×	71	4.1k
Phei Er Saw China	40	2.2k 0.9×	3.0k 1.2×	973 0.6×	975 0.6×	1.3k 0.8×	126	6.3k
Rui Kuai United States	26	1.9k 0.8×	1.8k 0.7×	841 0.5×	1.7k 1.1×	1.2k 0.8×	40	4.3k
Yinlong Zhang China	46	4.1k 1.7×	4.0k 1.7×	1.2k 0.8×	1.4k 0.9×	2.6k 1.7×	93	8.4k
Tianjiao Ji China	42	2.7k 1.1×	3.1k 1.3×	756 0.5×	812 0.5×	1.8k 1.2×	128	6.7k
Xuexiang Han China	42	2.1k 0.8×	2.6k 1.1×	815 0.5×	840 0.5×	1.2k 0.8×	64	5.4k

Countries citing papers authored by Lin‐Lin Bu

Since Specialization

Citations

This map shows the geographic impact of Lin‐Lin Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Lin Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Lin Bu more than expected).

Fields of papers citing papers by Lin‐Lin Bu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin‐Lin Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Lin Bu. The network helps show where Lin‐Lin Bu may publish in the future.

Co-authorship network of co-authors of Lin‐Lin Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Lin‐Lin Bu. A scholar is included among the top collaborators of Lin‐Lin Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin‐Lin Bu. Lin‐Lin Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zi‐Zhan, Yi Liu, Lei‐Ming Cao, et al.. (2025). Cuproptosis-based nanomedicine in cancer metastasis synergistic therapy. Acta Pharmaceutica Sinica B.

Xu, Jia, Yi Liu, Guangzheng Zhang, et al.. (2025). MnOx nanoflower-based ultrasound-responsive drug delivery for sonodynamic therapy of wound infections. Ultrasonics Sonochemistry. 121. 107530–107530. 1 indexed citations

Lin, Hao, Xuepeng Xiong, Zhe Shao, et al.. (2025). Vascularized iliac crest free flap in maxillofacial reconstruction: Pearls and pitfalls from 437 clinical application. Journal of Stomatology Oral and Maxillofacial Surgery. 126(3). 102318–102318.

Cao, Li‐Ming, Bailin Zhang, Hong Luo, et al.. (2025). Areca Nut Production, Imports, and Their Impact on Oral Cancer Incidence. Journal of Dental Research. 105(2). 207–216. 3 indexed citations

Bu, Lin‐Lin. (2025). Inhibition of STAT3 reduces proliferation and invasion in salivary gland adenoid cystic carcinoma: Am J Cancer Res. 2015; 5(5): 1751-1761. American Journal of Cancer Research. 15(12). 5386–5390. 1 indexed citations

Cao, Lei‐Ming, Yuan-ye Qiu, Zi‐Zhan Li, et al.. (2025). Extracellular Vesicles: Hermes between cancers and lymph nodes. Cancer Letters. 623. 217735–217735. 1 indexed citations

Zhong, Nian‐Nian, Yao Xiao, Zhengfei Zhu, et al.. (2025). NR2F2 and its contribution to lymph node metastasis in oral squamous cell carcinoma. Cellular Signalling. 132. 111814–111814. 2 indexed citations

Zhu, Wentao, Fang‐Yi Huo, Lei‐Ming Cao, et al.. (2025). Two-photon polymerization 3D printing of biomimetic microstructures for functionalizing surfaces to inhibit bacterial growth. Chemical Engineering Journal. 511. 161907–161907. 1 indexed citations

Li, Zi‐Zhan, Nian‐Nian Zhong, Lei‐Ming Cao, et al.. (2024). Nanoparticles Targeting Lymph Nodes for Cancer Immunotherapy: Strategies and Influencing Factors (Small 19/2024). Small. 20(19). 3 indexed citations

10.

Li, Zi‐Zhan, Wen-Tao Zhu, Nian‐Nian Zhong, et al.. (2024). Lymph node metastasis diagnosis of postoperative OSCC patients by analyzing extracellular vesicles in drainage fluid based on microfluidic isolation. Journal of Nanobiotechnology. 22(1). 586–586. 14 indexed citations

11.

Li, Haoying, Lin‐Lin Bu, Xiaoqi Sun, et al.. (2024). Mechanistic investigation of the ameliorative effect of liquiritin on hypoxia/reoxygenation‑induced cardiomyocyte injury based on network pharmacology and in vitro validation. Experimental and Therapeutic Medicine. 27(3). 117–117.

12.

Wang, Hanqi, et al.. (2023). Advances in CAR-T Cell Therapy in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine. 12(6). 2173–2173. 20 indexed citations

13.

Wu, Lei, Yuan‐Tong Liu, Wei‐Wei Deng, et al.. (2023). OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. International Journal of Molecular Sciences. 24(16). 12904–12904. 9 indexed citations

14.

Cheng, Boran, Lei Cao, Chen Li, et al.. (2023). Fluorine-doped carbon quantum dots with deep-red emission for hypochlorite determination and cancer cell imaging. Chinese Chemical Letters. 35(6). 108969–108969. 29 indexed citations

15.

Wu, Lei, Liang Mao, Jianfeng Liu, et al.. (2019). Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma. Cancer Immunology Research. 7(10). 1700–1713. 164 indexed citations

16.

Chen, Lei, Qi‐Chao Yang, Yicun Li, et al.. (2019). Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma. Cancer Immunology Research. 8(2). 179–191. 105 indexed citations

17.

Xiong, Hong‐Gang, Hao Li, Yao Xiao, et al.. (2019). Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 38(1). 278–278. 82 indexed citations

18.

Rao, Lang, Wenbiao Wang, Qian‐Fang Meng, et al.. (2018). A Biomimetic Nanodecoy Traps Zika Virus To Prevent Viral Infection and Fetal Microcephaly Development. Nano Letters. 19(4). 2215–2222. 66 indexed citations

19.

Rao, Lang, Qian‐Fang Meng, Lin‐Lin Bu, et al.. (2017). Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor Imaging. ACS Applied Materials & Interfaces. 9(3). 2159–2168. 215 indexed citations

20.

Rao, Lang, Bo Cai, Lin‐Lin Bu, et al.. (2017). Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. ACS Nano. 11(4). 3496–3505. 470 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact